coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    North Lewisham PCN, Lewisham (LAD) · Health Inequalities Profile

    PCN U53896 · NHS South East London Integrated Care Board · 10 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    87,733

    Registered population

    77.5% aged 18–64

    8.0%

    Aged 65+

    ICB 13.5% · England 17.9%

    49.5%

    Ethnic minority (non-White)

    11.9% Asian · England 9.6%

    15.1%

    In IMD quintile 1

    ICB 11.4% · England 21.0%

    ~19,453

    Core20 residents (est.)

    see page 3

    8,445

    Hypertension register

    +5.49% in 3 yrs · England +5.60%

    1,154

    SMI register

    21.8% of Lewisham (LAD)'s

    980

    COPD register

    Reviews +6.85% in 3 yrs

    Forecast to 2030

    9,607

    Hypertension patients, 2030

    +1,162 on today

    64.7%

    QRISK ≥20% on statins, 2030

    +1.50pp over 3 yrs

    2.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    61.2%
    Under-80 blood pressure control trails England.

    Control is 61.2% against 67.8% in England after falling 3.1% over 2023 to 2025 (England +3.2%), which may reflect unverified working-age review gaps.

    -8.1 pp
    Psychosis alcohol and SMI physical checks lag.

    Psychosis alcohol recording fell 8.1 pp to 72.3% (England +5.4 pp), while SMI BMI (72.8%) and blood pressure (76.3%) checks trail England.

    78.8%
    COPD and asthma review rates exceed England.

    COPD annual reviews reached 78.8% (+6.8% vs England +2.8%) and asthma reviews 68.1% (England 65.7%), though about 1,200 asthma patients remain unreviewed.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Working-age adults form 77.5% of registrations alongside an ethnic minority share of 49.5%

    Registered patient lists (87,733 total) show 77.5% aged 18–64, above Lewisham (72.8%), NHS South East London ICB (69.6%) and England (62.7%), with 8.0% aged 65+ (LAD 9.9%, ICB 13.5%, England 17.9%). Local Census estimates, rather than GP registers, record a 49.5% ethnic minority share, including 24.6% Black / African / Caribbean / Black British residents (LAD 26.8%, ICB 19.5%, England 4.2%) and 11.9% Asian / Asian British residents (LAD 9.0%, ICB 9.5%, England 9.6%). Services may need flexible scheduling and culturally tailored communication to engage these large working-age and diverse cohorts.

    Age profile

    0–1714.5%
    18–6477.5%
    65+8.0%

    65+: ICB 13.5%, England 17.9%

    Ethnicity

    White50.5%
    Black24.6%
    Asian11.9%
    Mixed7.7%
    Other5.3%

    Older people · falls rows are Lewisham (LAD) local-authority (LA) data, not PCN

    MeasureLocalLondonEnglandPeriod
    Falls admissions, 65+, per 100,000 (Lewisham LA)2,1192,0451,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)79.6%82.7%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)53.5%56.9%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Lewisham LA)1,2311,0699552024/25
    Falls deaths, all ages, per 100,000 (Lewisham LA)13.111.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Registered Core20 share is 15.1% but spans 29.7 percentage points across constituent practices

    North Lewisham PCN has an average IMD decile of 4.3 (Lewisham 4.1, ICB 5.3, England 5.5). Registered Core20 share is 15.1%, below Lewisham (20.1%), above the ICB (11.4%) and below England (21.0%). Practice deprivation spans 29.7 pp, from 0.0% at Vesta Road Surgery to 29.7% at New Cross Centre (hurley Group). Resident estimates show about 19,500 people in deciles 1 and 2 (14,400 aged 18-64; 3,635 aged 0-17), though resident and registered bases differ. Outreach should focus on practices with high Core20 shares to address sharp intra-PCN inequalities.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    New Cross Centre29.7% · 2,735 patients
    Clifton Rise26.2% · 1,081 patients
    Kingfisher24.4% · 3,742 patients
    Amersham Vale20.6% · 3,312 patients
    Qrp16.4% · 1,361 patients
    Deptford10.4% · 1,125 patients
    Grove1.8% · 234 patients
    Vesta Road0.0% · 0 patients
    Deptford0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    1,154

    SMI register

    1.26% recorded prevalence

    367

    Learning disability register

    0.40% recorded prevalence

    5

    Care homes, 237 beds

    In the PCN catchment

    7.7%

    Provide unpaid care

    Lewisham (LAD), Census 2021

    The PCN records 1,154 severe mental illness patients (1.3% prevalence vs LAD 1.5%, ICB 1.2%, England 1.0%) and 367 learning disability patients (0.4% vs LAD 0.6%, ICB 0.5%, England 0.6%). Five catchment care homes contain 237 beds. The severe mental illness register is above England, so physical-health checks for this cohort could be the key workload to protect.

    Severe mental illness: physical health checks

    SMI physical health checks trail England: blood pressure checks reached 76.3% (England 83.4%), BMI was 72.8% (England 82.1%), and alcohol recording for psychosis fell 8.1 pp over 2023 to 2025 to 72.3% (England +5.4 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,445

    Hypertension register

    +5.49%

    Register growth, 3 yrs

    Lewisham (LAD) +3.77% · England +5.60%

    −1.99pp

    BP control, under 80

    ≤140/90 · +4.72pp aged 80+

    +1,162

    More patients by 2030

    Forecast 9,607 (10.25%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 9.2% (8,445 patients), below Lewisham (11.5%), the ICB (12.1%), and England (15.2%), with an implied base of 91,694 against 87,733 registered patients. Recent blood pressure checks reached 85.2% (England 90.0%). For patients aged under 80, blood pressure control is 61.2%, below Lewisham (62.9%), the ICB (66.9%), and England (67.8%), after falling 3.1% over 2023 to 2025 (England +3.2%). For patients aged 80 and over, blood pressure control reached 76.9% (England 81.2%), rising 6.5% over 2023 to 2025 (England +2.2%). Overall blood pressure treated to target is 63.3% (England 70.3%). Lower under-80 control may reflect routine review pressures, which board recall could address.

    Lipids and statins

    Among patients with QRISK ≥ 20%, 61.6% receive lipid-lowering therapy, trailing Lewisham (61.7%), the ICB (62.4%), and England (63.6%), with 2023 to 2025 growth of 2.5% behind England (+6.2%). Patients with diabetes and CVD treated with a statin reached 85.1% (England 84.4%). Primary prevention statin uptake trails national benchmarks.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202655,111£2.00£1.71£1.86£110,222
    Cardiovascular (all), 202580,590£3.73£3.41£3.33£300,601

    In 2025, cardiovascular drug cost was £3.73 per item, spending £32,236 more than at England's unit cost across 80,590 items. Lipid-modifying drug cost was £2.00 per item, spending £8,287 more than at England's unit cost across 46,037 items. Higher unit costs may reflect prescribing choices across constituent practices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +0.49%

    Asthma reviews, PCN 3-yr change

    +4.44%

    Asthma reviews, England

    +3.07%

    Asthma prevalence, PCN

    Annual respiratory reviews exceed national averages: COPD review coverage is 78.8% across 980 registered patients (England 76.4%), and asthma review coverage is 68.1% across 3,840 patients (England 65.7%). However, an estimated scale gap of about 1,200 asthma patients remains without a recorded review in the last 12 months. Concurrently, asthma management prescribing for ages 5-19 is 1,331 items per 1000 population, above the ICB rate of 1,091 but below England's 1,488. A sizeable unreviewed asthma cohort persists alongside elevated youth prescribing relative to the ICB.

    Cancer register and children's immunisation

    Crude recorded cancer prevalence is 1.9% (England 3.8%). In Q1 2025/26, childhood immunisation coverage was below the 95.0% target: 6-in-1 at 12 months was 88.0% and MMR dose 1 at 24 months was 86.4%. At age 5, MMR dose 2 was 74.1% (10.7 pp below dose 1; 20.9 pp below target) and 4-in-1 booster coverage was 64.6% (below target by 30.4 pp). Coverage declines by school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months88.0%

    England 91.0%

    6-in-1 complete primary course at 24 months89.8%

    England 92.2%

    MMR dose 1 at 24 months86.4%

    England 88.3%

    MMR dose 2 at age 574.1%

    England 82.8%

    4-in-1 pre-school booster at age 564.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    54.4%

    South East London ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,100

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022South East London ICBEnglandNo usable stageStaged cancers
    Prostate59.6%53.2%27%1,108
    Breast81.2%85.4%27%986
    Lung33.5%33.8%17%792
    Bowel43.3%47.0%28%679
    Skin cancer89.2%87.8%35%223

    In 2022, 54.4% of cancers with a known stage (2,904 of 5,337) in NHS South East London ICB were diagnosed at stage 1 or 2, trailing England (55.3%) with distance to the 75.0% national ambition by 2028 at -20.6 pp. Reaching 75.0% requires about 1,100 extra early-stage diagnoses yearly across the ICB, where early-stage share rose +2.9 pp from 2013 to 2022. Staging data reflects system activity, not PCN performance; known-stage completeness was 60.8% (5,337 of 8,785). North Lewisham PCN cervical screening is 61.7% (England 66.8%). Improving primary care screening uptake is essential to support earlier system diagnosis.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For Lewisham and Greenwich NHS Trust, distance to the 28-day faster diagnosis standard (75.0%) is 8.7 pp. However, distance to the 62-day referral to treatment standard (85.0%) is -16.0 pp, and distance to the 31-day combined treatment standard (96.0%) is -0.8 pp. Across NHS South East London Integrated Care Board, distance to the 28-day standard is 8.5 pp, distance to the 62-day standard is -15.8 pp, and distance to the 31-day standard is -2.1 pp. These provider and ICB metrics show prompt initial diagnosis alongside treatment delays.

    Pathways within standard (%)Lewisham and GreenwichKing's CollegeGuy's and St Thomas'South East London ICBEngland
    28-day faster diagnosis (75%)83.7480.6886.7983.4779.32
    31-day treatment (96%)95.2496.6890.3693.8592.50
    62-day referral to treatment (85%)68.9870.1561.5069.1771.16
    Diagnostic waits over 6 weeks (%)Lewisham and GreenwichKing's CollegeGuy's and St Thomas'England
    MRI2.3021.2222.4821.40
    CT10.2122.6020.089.92
    Echocardiography6.8214.3920.6728.48
    Colonoscopy19.6541.817.5130.83
    Gastroscopy9.4235.9814.7029.02
    All 15 DM01 tests27.5819.1525.5123.14
    Community services activityLewisham residentsSouth East London ICB
    Care contacts56,080296,060
    Referrals7,84545,320
    Patients with a contact14,22080,720

    Community services (residents of Lewisham), Jun 2026 (provisional). In the Community Services Dataset (provisional June 2026), adults aged 65 and over accounted for 50% of contacts for Lewisham borough residents (28,020 of 56,080 total contacts). These figures reflect activity across the local authority rather than PCN-level provision, demonstrating substantial community service contact with older residents across the wider borough.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Good practice experience spans 33.3 percentage points from 52.2% to 85.4% across practices

    In 2025/26, QOF overall achievement ranged from 37.4% at One Care Lewisham to 99.5% at Amersham Vale Training Practice against England's 92.5%. Vaccination and immunisation domain achievement spanned 84.4 pp, from 15.6% at Clifton Rise Family Practice to 100.0% at Amersham Vale Training Practice.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Grove1201.870.4%61.7%85.4%
    One Care Lewisham18—71.2%30.5%84.7%
    Deptford990.070.5%83.2%82.1%
    Kingfisher11324.460.2%85.6%81.6%
    Clifton Rise11126.263.8%59.3%81.3%
    Vesta Road Surgery770.039.8%64.5%75.5%
    Deptford Surgery13810.465.6%74.8%73.6%
    Amersham Vale11320.654.6%69.4%70.7%
    New Cross Centre10729.750.8%62.6%66.9%
    The Qrp Surgery9916.432.8%69.7%52.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNLewisham (LAD)AssetPCNLewisham (LAD)
    Care homes (catchment)5 (237 beds)n/aSchools (catchment)67n/a
    Children's centres46Places of worship37106
    Libraries26Day centres (VCS)n/a1
    Carers support groups (VCS)n/a1Primary schools (LA maintained)1453
    Primary academies812Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Under-80 blood pressure titration recall

    Under-80 blood pressure control is 61.2% (Lewisham 62.9%, ICB 66.9%, England 67.8%), falling 3.1% over 2023 to 2025 (England +3.2%) across 8,445 hypertension patients. For discussion: run a structured recall and pharmacist-led medication titration clinic for registered under-80 hypertensive patients above target. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Combined SMI physical health recall

    Across 1,154 SMI patients (1.3% prevalence; 21.8% of Lewisham's register), BP checks are 76.3% (England 83.4%), BMI is 72.8% (England 82.1%), and alcohol recording fell 8.1 pp to 72.3% (England 81.8%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Structured annual asthma review recall

    Asthma review coverage is 68.1% of 3,840 registered patients (Lewisham 63.0%, ICB 65.4%, England 65.7%), with +0.5% three-year change trailing England's +4.4% and an estimated scale gap of 1,225 patients (about 1,200). For discussion: align annual asthma recall with repeat inhaler prescribing reviews and offer after-school or flexible clinic slots. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Culturally tailored access review (p2)Black / African / Caribbean / Black BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Systematic SMI physical health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Working age blood pressure recall (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster outreach and recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice access and triage review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Under-80 blood pressure titration recall (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Combined SMI physical health recall (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Option 3 · Structured annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15